|
DNAJC11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.14230003234184E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.47099996020239E-09 |
| Normal-vs-Stage2 |
5.248100E-02 |
| Normal-vs-Stage3 |
2.5259999980598E-08 |
| Normal-vs-Stage4 |
1.36480049484078E-10 |
| Stage1-vs-Stage2 |
3.181000E-03 |
| Stage1-vs-Stage3 |
4.275200E-01 |
| Stage1-vs-Stage4 |
2.201900E-02 |
| Stage2-vs-Stage3 |
3.136800E-03 |
| Stage2-vs-Stage4 |
1.237150E-04 |
| Stage3-vs-Stage4 |
1.423570E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.5637995039225E-10 |
| Normal-vs-AfricanAmerican |
2.595100E-03 |
| Normal-vs-Asian |
2.435400E-04 |
| Caucasian-vs-AfricanAmerican |
3.172800E-01 |
| Caucasian-vs-Asian |
2.478600E-01 |
| AfricanAmerican-vs-Asian |
9.114400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.32080000053914E-07 |
| Normal-vs-Female |
9.90480031326513E-10 |
| Male-vs-Female |
9.187600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.41270003765015E-09 |
| Normal-vs-Age(41-60Yrs) |
1.11929999713212E-08 |
| Normal-vs-Age(61-80Yrs) |
3.10349999999016E-06 |
| Normal-vs-Age(81-100Yrs) |
3.874400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.480000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.897600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.910200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.521000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.434200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.048800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.953050E-01 |
| Classical-VS-Follicular |
5.585600E-01 |
| Classical-VS-Other |
3.117600E-01 |
| Classical-VS-Normal |
7.03159996895408E-09 |
| Tall-VS-Follicular |
1.087220E-01 |
| Tall-VS-Other |
7.286200E-01 |
| Tall-VS-Normal |
7.77769999960043E-07 |
| Follicular-VS-Other |
3.030000E-01 |
| Follicular-VS-Normal |
7.59230000000333E-05 |
| Other-VS-Normal |
2.324900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.15020000002186E-06 |
| Normal-vs-N1 |
4.51889969887986E-10 |
| N0-vs-N1 |
4.924800E-03 |
|
|
